Literature DB >> 9402389

Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil.

R Dietze1, G B Barros, L Teixeira, J Harris, K Michelson, A Falqueto, R Corey.   

Abstract

In Brazil, where Leishmania chagasi causes endemic American visceral leishmaniasis (AVL), the spread and maintenance of human disease are attributed to canine reservoirs. However, despite measures directed toward the elimination of infected canines, the incidence of human disease continues to increase. To evaluate the role of infected canines in the acquisition of AVL by humans, we undertook a controlled intervention study in three similar, but isolated, valleys of Pancas, Espírito Santo, Brazil. In the two experimental (intervention) valleys, infected dogs were eliminated whereas in the control valley, seropositive canines remained untouched. During the 12-month study period, human seropositivity rates, as measured by dot enzyme-linked immunosorbent assay, increased from 15% to 54% in the intervention valleys and from 14% to 54% in the control valley. The elimination of infected canines in the intervention valleys did not result in a statistically significant difference between the incidences of human serological conversion in the intervention and control valleys at either 6 (20% and 22%, respectively; P = .5961) or 12 months (26% and 27%, respectively; P = .9442). The role of humans as a significant reservoir for AVL is proposed as an explanation for the study results.

Entities:  

Mesh:

Year:  1997        PMID: 9402389     DOI: 10.1086/516096

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  39 in total

1.  The effect of removing potentially infectious dogs on the numbers of canine Leishmania infantum infections in an endemic area with high transmission rates.

Authors:  Gabriel Grimaldi; Antonio Teva; Claudiney B Santos; Adelson L Ferreira; Aloísio Falqueto
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Leishmaniasis at the End of the Millennium.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.725

3.  Development of a dipstick assay for detection of Leishmania-specific canine antibodies.

Authors:  Henk D F H Schallig; Luís Cardoso; Marieke Hommers; Nel Kroon; Guus Belling; Manuela Rodrigues; Saul J Semião-Santos; Hans Vetter
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

4.  Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology.

Authors:  L Solano-Gallego; P Morell; M Arboix; J Alberola; L Ferrer
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Diagnosis of canine leishmaniasis in the endemic area of Belo Horizonte, Minas Gerais, Brazil by parasite, antibody and DNA detection assays.

Authors:  E S da Silva; W F van der Meide; G J Schoone; C M F Gontijo; H D F H Schallig; R P Brazil
Journal:  Vet Res Commun       Date:  2006-08       Impact factor: 2.459

6.  Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.

Authors:  Joelma Trigo; Melissa Abbehusen; Eduardo M Netto; Maria Nakatani; Geraldo Pedral-Sampaio; Robson Silva de Jesus; Yasuyuki Goto; Jeffrey Guderian; Randall F Howard; Steven G Reed
Journal:  Vaccine       Date:  2010-03-04       Impact factor: 3.641

7.  Canine leishmaniasis in Brazil: serological follow-up of a dog population in an endemic area of american visceral leishmaniasis.

Authors:  Alba Valéria Machado da Silva; Adelzon Assis de Paula; Daniela de Pita Pereira; Reginaldo Peçanha Brazil; João Carlos Araujo Carreira
Journal:  J Parasitol Res       Date:  2010-01-13

8.  Canine visceral leishmaniosis in Anastácio, Mato Grosso do Sul state, Brazil.

Authors:  V M C L Cortada; M E C Doval; M A A Souza Lima; E T Oshiro; C R V Meneses; A L Abreu-Silva; E Cupolilo; C S F Souza; F O Cardoso; T Zaverucha do Valle; R P Brazil; K S Calabrese; S C Gonçalves da Costa
Journal:  Vet Res Commun       Date:  2004-07       Impact factor: 2.459

9.  Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis.

Authors:  J Moreno; J Nieto; S Masina; C Cañavate; I Cruz; C Chicharro; E Carrillo; S Napp; C Reymond; P M Kaye; D F Smith; N Fasel; J Alvar
Journal:  Vaccine       Date:  2007-06-04       Impact factor: 3.641

Review 10.  Control of visceral leishmaniasis in latin america-a systematic review.

Authors:  Gustavo A S Romero; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2010-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.